{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-035535","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2026-05-15T20:00:10+00:00","discovered_at":"2026-05-15T20:01:10.761611+00:00","generated_at":"2026-05-15T20:01:19.269977+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Skye Bioscience receives Nasdaq delisting notice for failing minimum stockholders' equity","bullets":["Stockholders' equity was $9,011,804, below Nasdaq Global Market's $10M minimum requirement.","Nasdaq gave 45 days (until June 29, 2026) to submit a compliance plan; extension possible to Nov 9, 2026.","No immediate impact on trading; stock continues to trade under 'SKYE'.","Company is evaluating alternative courses of action to regain compliance; no assurance of success."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-035535","json":"https://secwatch.observer/filing/0001628280-26-035535.json","markdown":"https://secwatch.observer/filing/0001628280-26-035535.md","text":"https://secwatch.observer/filing/0001628280-26-035535.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026035535/0001628280-26-035535-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026035535/skye-20260513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T20:01:19.269977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b3ad98b12bcae68f77ce67307032ec7bd5c5757e","claim":"Skye Bioscience, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5450(b)(1)(A), 5810(c)(2)(C)).","evidence_excerpt":"May 13, 2026 , Skye Bioscience, Inc. (the “Company” or “Skye”) received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026035535/0001628280-26-035535-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5450(b)(1)(A), 5810(c)(2)(C)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}